# Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding

> **NCT04878614** · PHASE4 · TERMINATED · sponsor: **University of California, Los Angeles** · enrollment: 3 (actual)

## Conditions studied

- Hypothyroidism

## Interventions

- **DRUG:** Levothyroxine Tablet
- **DRUG:** Levothyroxine Sodium

## Key facts

- **NCT ID:** NCT04878614
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-05
- **Primary completion:** 2022-02-16
- **Final completion:** 2022-02-16
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Sponsor terminated study low accrual numbers
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04878614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04878614, "Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04878614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*